Comparative analysis of selected exhaled breath biomarkers obtained with two different temperature-controlled devices

[1]  T. Brüning,et al.  Exhaled breath condensate and airway inflammation , 2009, Current opinion in allergy and clinical immunology.

[2]  E. Sapey,et al.  The validation of assays used to measure biomarkers in exhaled breath condensate , 2008, European Respiratory Journal.

[3]  Ildikó Horváth,et al.  Influence of condensing equipment and temperature on exhaled breath condensate pH, total protein and leukotriene concentrations. , 2008, Respiratory medicine.

[4]  Q. Jöbsis,et al.  Biomarker reproducibility in exhaled breath condensate collected with different condensers , 2008, European Respiratory Journal.

[5]  R. Stockley,et al.  Validation of assays for inflammatory mediators in exhaled breath condensate , 2008, European Respiratory Journal.

[6]  K. Kostikas,et al.  Biomarkers in the exhaled breath condensate of healthy adults: mapping the path towards reference values. , 2008, Current medicinal chemistry.

[7]  J. Michel,et al.  The Oral Cavity and Age: A Site of Chronic Inflammation? , 2007, PloS one.

[8]  T. Brüning,et al.  Exhaled breath condensate analysis: evaluation of a methodological setting for epidemiological field studies. , 2007, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[9]  D. Yates,et al.  Collection devices influence the constituents of exhaled breath condensate , 2007, European Respiratory Journal.

[10]  L. Prieto,et al.  Differences in exhaled breath condensate pH measurements between samples obtained with two commercial devices. , 2007, Respiratory medicine.

[11]  I. Horváth,et al.  Exhaled breath condensate pH standardised for CO2 partial pressure , 2007, European Respiratory Journal.

[12]  P. Montuschi,et al.  Insights into oxidative stress: the isoprostanes. , 2007, Current medicinal chemistry.

[13]  D. Yates,et al.  Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage. , 2007, American journal of respiratory and critical care medicine.

[14]  S. Dahlén,et al.  Saliva is one likely source of leukotriene B4 in exhaled breath condensate , 2006, European Respiratory Journal.

[15]  Q. Jöbsis,et al.  Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate , 2006, European Respiratory Journal.

[16]  O. Kalayci,et al.  Comparison of two methods for exhaled breath condensate collection , 2006, Allergy.

[17]  A. Paget-Brown,et al.  Normative data for pH of exhaled breath condensate. , 2006, Chest.

[18]  E. Yung,et al.  Clinical and Technical Factors Affecting pH and Other Biomarkers in Exhaled Breath Condensate , 2006, Pediatric pulmonology.

[19]  L. Bjermer,et al.  Methodological improvements for measuring eicosanoids and cytokines in exhaled breath condensate. , 2006, Respiratory medicine.

[20]  P. J. Barnes,et al.  Exhaled breath condensate: methodological recommendations and unresolved questions , 2005, European Respiratory Journal.

[21]  M. Corradi,et al.  Heart rate variability in non-apneic snorers and controls before and after continuous positive airway pressure , 2005, BMC Pulmonary Medicine.

[22]  K. Chung,et al.  Adenosine 5'-monophosphate increases levels of leukotrienes in breath condensate in asthma. , 2004, Respiratory medicine.

[23]  L. Dupont,et al.  Quantitative analysis of 8‐isoprostane and hydrogen peroxide in exhaled breath condensate , 2004, European Respiratory Journal.

[24]  A Smith,et al.  Exhaled breath condensate pH is a robust and reproducible assay of airway acidity , 2003, European Respiratory Journal.

[25]  P. Barnes,et al.  Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD , 2003, Thorax.

[26]  M. Griese,et al.  Protein pattern of exhaled breath condensate and saliva , 2002, Proteomics.

[27]  Konstantinos Kostikas,et al.  pH in expired breath condensate of patients with inflammatory airway diseases. , 2002, American journal of respiratory and critical care medicine.

[28]  Paolo Montuschi,et al.  Analysis of exhaled breath condensate for monitoring airway inflammation. , 2002, Trends in pharmacological sciences.

[29]  P. Montuschi,et al.  Exhaled leukotrienes and prostaglandins in asthma. , 2002, The Journal of allergy and clinical immunology.

[30]  M. Gare,et al.  Dilution of respiratory solutes in exhaled condensates. , 2002, American journal of respiratory and critical care medicine.

[31]  P. Barnes,et al.  Biomarkers of some pulmonary diseases in exhaled breath , 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[32]  G. Papatheodorou,et al.  Total nitrite/nitrate in expired breath condensate of patients with asthma. , 2001, Respiratory medicine.

[33]  P. Barnes,et al.  Increased nitrotyrosine in exhaled breath condensate of patients with asthma. , 2000, American journal of respiratory and critical care medicine.

[34]  E. Troncy,et al.  Effects of reducing reagents and temperature on conversion of nitrite and nitrate to nitric oxide and detection of NO by chemiluminescence. , 1997, Clinical chemistry.

[35]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[36]  A. Buist.  Standardization of spirometry. , 1987, The American review of respiratory disease.

[37]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[38]  M. Hills,et al.  The two-period cross-over clinical trial. , 1979, British journal of clinical pharmacology.

[39]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.